DR. ALBERT MARK GOLD, PH.D.
Medical Practice at Kingfisher Ct, Frederick, MD
License number
Maryland 96059
Category
Medical Practice
Type
Clinical Molecular Genetics
Address
Address
6811 Kingfisher Ct, Frederick, MD 21703
Phone
(301) 360-0699
Professional information
Dr. Albert M Gold, Frederick MD - MD (Doctor of Medicine)
Specialties:
Clinical Molecular Genetics
Address:
6811 Kingfisher Ct, Frederick 21703
(301) 360-0699 (Phone)
(301) 360-0699 (Phone)
Certifications:
Clinical Molecular Genetics, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Fellowship Hospital
Uc San Francisco
Uc San Francisco
Variants In Complement Regulatory Genes Predict Age-Related Macular Degeneration
US Patent:
8012683, Sep 6, 2011
Filed:
Feb 13, 2007
Appl. No.:
11/706074
Inventors:
Rando L. Allikmets - Cornwall on Hudson NY, US
Gregory S. Hageman - Coralville IA, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Gregory S. Hageman - Coralville IA, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
The Trustees of Columbia University in the City of New York - New York NY
United States of America, as represented by the Secretary of the Department of Health and Human Services - Washington DC
The Trustees of Columbia University in the City of New York - New York NY
United States of America, as represented by the Secretary of the Department of Health and Human Services - Washington DC
International Classification:
C12Q 1/68, C12P 19/34
US Classification:
435 6, 435 911
Abstract:
Methods for identifying a subject at risk for developing AMD are disclosed, as are kits which can be used to practice the methods. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material, including polymorphisms in the BF, C2 and/or CFH genes. Microarrays and kits for use in these methods are also provided.
Protective Complement Proteins And Age-Related Macular Degeneration
US Patent:
2008014, Jun 19, 2008
Filed:
Feb 13, 2007
Appl. No.:
11/706154
Inventors:
Gregory S. Hageman - Coralville IA, US
Rando Allikmets - Cornwall on Hudson NY, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Rando Allikmets - Cornwall on Hudson NY, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
The Trustees of Columbia University in The City of New York - New York NY
National Institutes of Health Office of Technology Transfer - Rockville MD
The Trustees of Columbia University in The City of New York - New York NY
National Institutes of Health Office of Technology Transfer - Rockville MD
International Classification:
A61K 38/16, C07K 14/00, A61P 27/02
US Classification:
514 12, 530350
Abstract:
Methods for identifying a subject at risk for developing AMD are disclosed. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material. Therapeutic compositions and methods are also provided for delaying the progression or onset of the development of AMD in a subject, including treating a subject having signs and/or symptoms of AMD or who has been diagnosed with AMD.
Protective Complement Proteins And Age-Related Macular Degenration
US Patent:
2008028, Nov 13, 2008
Filed:
Aug 20, 2007
Appl. No.:
11/894784
Inventors:
Gregory S. Hageman - Coralville IA, US
Rando Allikmets - Cornwall on Hudson NY, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Rando Allikmets - Cornwall on Hudson NY, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
The Trustees of Columbia University in The City of New York - New York NY
National Institutes of Health Office of Technology Transfer - Rockville MD
The Trustees of Columbia University in The City of New York - New York NY
National Institutes of Health Office of Technology Transfer - Rockville MD
International Classification:
A61K 38/16, A61P 27/02
US Classification:
514 12
Abstract:
Methods for identifying a subject at risk for developing AMD are disclosed. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material. Therapeutic compositions and methods are also provided for delaying the progression or onset of the development of AMD in a subject, including treating a subject having signs and/or symptoms of AMD or who has been diagnosed with AMD.
Protective Complement Proteins And Age-Related Macular Degeneration
US Patent:
2010027, Oct 28, 2010
Filed:
Dec 22, 2009
Appl. No.:
12/645272
Inventors:
Gregory S. Hageman - Salt Lake City UT, US
Rando Allikmets - Cornwall on Hudson NY, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Rando Allikmets - Cornwall on Hudson NY, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Assignee:
University of lowa Research Foundation - lowa City IA
The Trustees of Columbia University in The City of New York - New York NY
National Institutes of Health Office of Technology Transfer - Rockville MD
The Trustees of Columbia University in The City of New York - New York NY
National Institutes of Health Office of Technology Transfer - Rockville MD
International Classification:
A61K 38/02, A61P 27/02
US Classification:
514 208
Abstract:
Methods for identifying a subject at risk for developing AMD are disclosed. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material. Therapeutic compositions and methods are also provided for delaying the progression or onset of the development of AMD in a subject, including treating a subject having signs and/or symptoms of AMD or who has been diagnosed with AMD.
Variants In Complement Regulatory Genes Predict Age-Related Macular Degeneration
US Patent:
2012007, Mar 22, 2012
Filed:
Aug 2, 2011
Appl. No.:
13/196121
Inventors:
Rando L. Allikmets - Cornwall on Hudson NY, US
Gregory S. Hageman - Salt Lake City UT, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Gregory S. Hageman - Salt Lake City UT, US
Michael C. Dean - Frederick MD, US
Albert M. Gold - Frederick MD, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
National Institutes of Health - Rockville MD
The Trustees of Columbia University in The City of New York - New York NY
National Institutes of Health - Rockville MD
The Trustees of Columbia University in The City of New York - New York NY
International Classification:
C40B 40/06, G01N 33/53, G01N 33/50, C12Q 1/68
US Classification:
506 16, 435 612, 435 792, 436501, 436 86, 435 61
Abstract:
Methods for identifying a subject at risk for developing AMD are disclosed, as are kits which can be used to practice the methods. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material, including polymorphisms in the BF, C2 and/or CFH genes. Microarrays and kits for use in these methods are also provided.